Generation of a gene-corrected isogenic control cell line from an Alzheimer's disease patient iPSC line carrying a A79V mutation in PSEN1-Reference-Cited by-同舟云学术

Generation of a gene-corrected isogenic control cell line from an Alzheimer's disease patient iPSC line carrying a A79V mutation in PSEN1

Published:2016-09 Issue:2 Volume:17 Page:285-288
ISSN:1873-5061
Container-title:Stem Cell Research
language:en
Short-container-title:Stem Cell Research

Author:

Pires Carlota,Schmid Benjamin,Petræus Carina,Poon Anna,Nimsanor Natakarn,Nielsen Troels T.,Waldemar Gunhild,Hjermind Lena E.,Nielsen Jørgen E.,Hyttel Poul,Freude Kristine K.^ORCID

Funder

European Union 7th Framework Program

Innovation Fund Denmark “Brainstem”

Publisher

Elsevier BV

Subject

Cell Biology,Developmental Biology,General Medicine

Reference3 articles.

1. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying an A79V mutation in PSEN1;Li;Stem Cell Res.,2016

2. A more efficient method to generate integration-free human iPS cells;Okita;Nat. Methods,2011

3. Genome engineering using the CRISPR-Cas9 system;Ran;Nat. Protoc.,2013

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CRISPR/Cas9 Gene Editing: A Novel Approach Towards Alzheimer's Disease Treatment;CNS & Neurological Disorders - Drug Targets;2024-12

2. Gene therapy for CNS disorders: modalities, delivery and translational challenges;Nature Reviews Neuroscience;2024-06-19

3. Efficient gene editing in induced pluripotent stem cells enabled by an inducible adenine base editor with tunable expression;Scientific Reports;2023-12-11

4. Application of CRISPR/Cas9 in the management of Alzheimer’s disease and Parkinson’s disease: a review;Annals of Medicine & Surgery;2023-11-16

5. Recent Advances in CRISPR/Cas9 Delivery Approaches for Therapeutic Gene Editing of Stem Cells;Stem Cell Reviews and Reports;2023-09-18